Eyecelerator @AAO 2021 - RETINA SHOWCASE

Get an inside look at next-generation interventions for age-related macular degeneration, photoreceptor survival and rejuvenation, and new strategies and devices with high promise, while panelists add expert insights and perspectives.

Moderators: Robert L. Avery, MD and Allen C. Ho, MD

Panel: Mark Blumenkranz, MD, Wiley Chambers, MD, Namrata Saroj, OD, Firas M. Rahhal, MD, Jeffry Weinhuff 

Start
Company
Presenter
1:00 PM
Notal Vision, Inc.
Kester Nahen, CEO
1:05 PM
Aldeyra Therapeutics, Inc.
Todd C. Brady, MD, PhD, President & CEO
1:10 PM
Outlook Therapeutics
Russell Trenary, MBA, President & CEO
1:15 PM
Discussion
Panel
1:23 PM
Stealth Biotherapeutics Inc.
Reenie McCarthy, JD, CEO
1:28 PM
Allegro Ophthalmics, LLC
Vicken Karageozian, MD, President & CEO
1:33 PM
LumiThera, Inc.
Clark E. Tedford, PhD, President & CEO
1:38 PM
Discussion
Panel
1:46 PM
OcuTerra Therapeutics
David Tanzer, MD, Chief Medical Officer
1:51 PM
UNITY Biotechnology
Anirvan Ghosh, PhD, CEO
1:56 PM
Graybug Vision
Fred Guerard, PharmD, Chief Executive Officer
2:01 PM
Discussion
Panel
2:09 PM
Oxular Ltd.
Thomas Cavanagh, MBA, CEO
2:14 PM
Vitranu, Inc.
Gordon Bethwaite, Chief Executive Officer
2:19 PM
Re-Vana Therapeutics
Michael O'Rourke, CEO
2:24 PM
Discussion
Panel